New UK Rare Disease Framework Seeks Better Patient Access & More International Collaboration
Executive Summary
England, Scotland, Wales and Northern Ireland will publish their respective action plans to deliver the aims of the UK’s new framework for rare diseases.
You may also be interested in...
England’s NICE Asks For Feedback On New Approach To Prioritizing HTAs
NICE, the health technology assessment body for England and Wales, plans to reform how it prioritizes therapies and topics for appraisal by introducing a single prioritization board and common framework.
New UK Rare Disease Framework Seeks To Reduce ‘Diagnostic Odyssey’ For Patients
England, Scotland, Wales and Northern Ireland will publish their respective action plans to deliver the aims of the UK’s new framework for rare diseases.
UK Conservatives Promise ‘Innovative Medicines Fund’ If Re-Elected
More money to pay for innovative new medicines, more cash and support for the life sciences sector, and Brexit by 31 January 2020 are among promises made in the Conservative Party’s election platform.